These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36460182)

  • 41. Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.
    Mastboom MJL; Verspoor FGM; Uittenbogaard D; Schaap GR; Jutte PC; Schreuder HWB; van de Sande MAJ
    Clin Orthop Relat Res; 2018 Sep; 476(9):1803-1812. PubMed ID: 29494352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis.
    Bickels J; Isaakov J; Kollender Y; Meller I
    J Bone Joint Surg Am; 2008 Feb; 90(2):326-8. PubMed ID: 18245592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effectiveness of arthroscopy and/or arthrotomy therapy for diffuse pigmented villonodular synovitis of the knee].
    Liu D; Li Q; Jiang X; Tang X; Li J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 May; 26(5):518-21. PubMed ID: 22702040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
    Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
    Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arthroscopic Versus Open Management of Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: A Meta-analysis of Retrospective Cohort Studies.
    Chandra AA; Agarwal S; Donahue A; Handorf E; Abraham JA
    J Am Acad Orthop Surg Glob Res Rev; 2021 Dec; 4(12):. PubMed ID: 34882586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.
    Mastboom MJ; Planje R; van de Sande MA
    Interact J Med Res; 2018 Feb; 7(1):e4. PubMed ID: 29475829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pigmented villonodular synovitis of the ankle-radiation therapy as a primary treatment to reduce recurrence: a case report with 8-year follow-up.
    Schnirring-Judge M; Lin B
    J Foot Ankle Surg; 2011; 50(1):108-16. PubMed ID: 21172644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pigmented villonodular synovitis.
    Mendenhall WM; Mendenhall CM; Reith JD; Scarborough MT; Gibbs CP; Mendenhall NP
    Am J Clin Oncol; 2006 Dec; 29(6):548-50. PubMed ID: 17148989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnetic resonance imaging features of intra-articular tenosynovial giant cell tumor in children.
    Nguyen JC; Biko DM; Nguyen MK; Othman S; Weber KL; Ganley TJ; Arkader A
    Pediatr Radiol; 2021 Mar; 51(3):441-449. PubMed ID: 33156428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of external beam radiation therapy in the adjuvant treatment of pigmented villonodular synovitis].
    Heyd R; Seegenschmiedt MH; Micke O
    Z Orthop Unfall; 2011 Dec; 149(6):677-82. PubMed ID: 21271510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment updates on tenosynovial giant cell tumor.
    Palmerini E; Staals EL
    Curr Opin Oncol; 2022 Jul; 34(4):322-327. PubMed ID: 35837703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints.
    Shabat S; Kollender Y; Merimsky O; Isakov J; Flusser G; Nyska M; Meller I
    Rheumatology (Oxford); 2002 Oct; 41(10):1113-8. PubMed ID: 12364629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pigmented villonodular synovitis. Review of 20 cases.
    Dürr HR; Stäbler A; Maier M; Refior HJ
    J Rheumatol; 2001 Jul; 28(7):1620-30. PubMed ID: 11469471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease.
    Somerhausen NS; Fletcher CD
    Am J Surg Pathol; 2000 Apr; 24(4):479-92. PubMed ID: 10757395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severity classification of Tenosynovial Giant Cell Tumours on MR imaging.
    Mastboom MJL; Verspoor FGM; Hanff DF; Gademan MGJ; Dijkstra PDS; Schreuder HWB; Bloem JL; van der Wal RJP; van de Sande MAJ
    Surg Oncol; 2018 Sep; 27(3):544-550. PubMed ID: 30217317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arthroscopic Excision of a Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report.
    Zmerly H; Draghetti M; Moscato M; Akkawi I
    Curr Rheumatol Rev; 2024; 20(4):459-464. PubMed ID: 38231053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
    Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
    Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
    Ravi V; Wang WL; Lewis VO
    Curr Opin Oncol; 2011 Jul; 23(4):361-6. PubMed ID: 21577109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inconclusive benefit of adjuvant
    Gortzak Y; Vitenberg M; Frenkel Rutenberg T; Kollender Y; Dadia S; Sternheim A; Morag G; Farkash U; Rath E; Kramer M; Drexler M
    Bone Joint J; 2018 Jul; 100-B(7):984-988. PubMed ID: 29954214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis of Advanced Tenosynovial Giant Cell Tumor of the Knee Diagnosed During Total Knee Arthroplasty.
    Lei P; Sun R; Liu H; Zhu J; Wen T; Hu Y
    J Arthroplasty; 2017 Jun; 32(6):1850-1855. PubMed ID: 28161138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.